Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478940 | SCV000568787 | uncertain significance | not provided | 2020-05-28 | criteria provided, single submitter | clinical testing | Functional studies indicate P932L results in reduced surface expression of CLCN1 protein (Macias et al., 2007); Functional studies demonstrate that P932L results in nearly wildtype chloride currents (Simpson et al., 2004); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19917643, 27653901, 18263754, 11933197, 15241802, 11113225, 12566541, 15786415, 23739125, 15311340, 29935101, 17107341, 32117034) |
Labcorp Genetics |
RCV000638250 | SCV000759736 | uncertain significance | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2023-12-28 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 932 of the CLCN1 protein (p.Pro932Leu). This variant is present in population databases (rs80356706, gnomAD 0.1%). This missense change has been observed in individual(s) with autosomal recessive myotonia congenita (PMID: 11113225, 23739125). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 17533). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CLCN1 protein function with a negative predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on CLCN1 function (PMID: 15241802, 17107341). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000478940 | SCV003832360 | uncertain significance | not provided | 2022-07-13 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000019085 | SCV000039373 | pathogenic | Congenital myotonia, autosomal recessive form | 2000-12-12 | no assertion criteria provided | literature only | |
Gene |
RCV000020108 | SCV000040428 | not provided | Batten-Turner congenital myopathy | no assertion provided | literature only |